NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN AND SOUTH AFRICA ...

The series initially aired in Canada in 2024 and captivated fans with the premise, with critics describing it as being "in a ...

Their method is the first to directly fix flaws in animals’ mitochondrial DNA, which are responsible for severe and deadly conditions.

GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies, has transferred ...

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and ...

Most gene therapies being studied for eye diseases are in earlier phases of development, and a third of the gene therapies ...

The leber hereditary optic neuropathy treatment market forecast strong growth in the coming years and is expected to reach $0.53 billion in 2029 at a compound annual growth rate CAGR of 7.8%.

Rosemount senior Nate Beyer wrestles for the Irish despite being diagnosed with Leber's Hereditary Optic Neuropathy (LHON).

Patrick Yu-Wai-Man et al, Five-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy, JAMA Ophthalmology (2024). DOI: 10.1001/jamaophthalmol.2024.5375 ...

Leber hereditary optic neuropathy (LHON) is an inherited form of vision loss that causes people to have trouble with their colour vision and difficulty seeing in the centre of their visual field.

Maryse Roger has firsthand experience of Leber’s hereditary optic neuropathy (LHON), having first assisted her two brothers as their sight deteriorated and then leading the care of her son ...